Transgender hormone therapy (male-to-female) medical professional. Inducers of CYP3A4 and other cytochrome P450 enzymes can reduce the effects of MTF HRT. A variety of different sex-hormonal medications are used in feminizing hormone therapy for transgender women. These include estrogens to induce feminization and suppress testosterone levels; antiandrogens such as androgen receptor antagonists, antigonadotropins, GnRH modulators, and 5α-reductase inhibitors to further oppose the effects of androgens like testosterone; and progestogens for various possible though uncertain benefits. Estrogens are the major sex hormones in women, and are responsible for the development and maintenance of feminine secondary sexual characteristics, such as breasts, wide hips, and a feminine
Fraternal birth order and male sexual orientation sexual orientation via the fraternal birth order effect (for example, homosexual men with no older brothers) owe their homosexuality to other causes such as certain polymorphic genes (colloquially called "gay genes") or prenatal hormone levels during fetal development. Both direct and indirect evidence have demonstrated that the mechanism by which the fraternal birth order effect operates is prenatal in timing and biological in nature, rather than postnatal in timing or psychosocial in nature. Indirect evidence was found first when it was discovered that the fraternal birth order effect interacts with birth weight. Then, Bogaert (2006) produced direct evidence that the